Clinical trial
Daphnetin Capsule In the Treatment of VaScular COgnitive Impairment Without Dementia - A Randomized, Double-blind, Placebo-controlled Study
NCT06507488 is registered in ClinicalTrials.gov with First People's Hospital of Shenyang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Daphnetin Capsule In the Treatment of VaScular COgnitive Impairment Without Dementia - A Randomized, Double-blind, Placebo-controlled Study
- Lead sponsor
- First People's Hospital of Shenyang
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 7, 2025
- Completion date
- July 7, 2027
- Enrollment
- 206 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.